Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

CHIEF FINANCIAL OFFICER

Chief Financial Officer

President and Head of R&D

Chief Executive Officer

CMO and Head of R&D

President and CEO

Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 for the treatment of for SLC13A5 Deficiency; and TSHA-101 for the treatment of GM2 gangliosidosis. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center to develop and commercialize transformative gene therapy treatments. The company was incorporated in 2019 and is based in Dallas, Texas.

Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-02-02	Premium	sold (taxes)	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2024-01-02	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-01-02	Premium	acquired	Premium	Premium	Premium	President and Head of R&D
2024-01-02	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2023-11-17	Premium	bought	Premium	Premium	Premium	-
2023-08-24	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-08-16	Premium	bought	Premium	Premium	Premium	-
2023-08-16	Premium	bought	Premium	Premium	Premium	-
2023-08-16	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2023-08-16	Premium	bought	Premium	Premium	Premium	-
2023-08-16	Premium	gifted	Premium	Premium	Premium	-
2023-07-13	Premium	sold	Premium	Premium	Premium	-
2023-07-12	Premium	sold	Premium	Premium	Premium	-
2023-06-23	Premium	sold	Premium	Premium	Premium	-
2023-06-22	Premium	sold	Premium	Premium	Premium	-
2023-06-21	Premium	sold	Premium	Premium	Premium	-
2023-06-20	Premium	sold	Premium	Premium	Premium	-
2023-05-31	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-05-16	Premium	bought	Premium	Premium	Premium	President and Head of R&D
2023-03-06	Premium	acquired	Premium	Premium	Premium	-
2023-02-02	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2022-10-31	Premium	bought	Premium	Premium	Premium	-
2022-08-23	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2022-08-22	Premium	sold	Premium	Premium	Premium	Chief Financial Officer

TSHA - Taysha Gene Therapies Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for TSHA